Standard Total Stockholder Equity vs Total Current Liabilities Analysis

LAB Stock  USD 1.94  0.08  3.96%   
Standard Biotools financial indicator trend analysis is much more than just breaking down Standard Biotools prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Standard Biotools is a good investment. Please check the relationship between Standard Biotools Total Stockholder Equity and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.

Total Stockholder Equity vs Total Current Liabilities

Total Stockholder Equity vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Standard Biotools Total Stockholder Equity account and Total Current Liabilities. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Standard Biotools' Total Stockholder Equity and Total Current Liabilities is 0.48. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Standard Biotools, assuming nothing else is changed. The correlation between historical values of Standard Biotools' Total Stockholder Equity and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Standard Biotools are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Stockholder Equity i.e., Standard Biotools' Total Stockholder Equity and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.48
Relationship DirectionPositive 
Relationship StrengthWeak

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Total Current Liabilities

Total Current Liabilities is an item on Standard Biotools balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Standard Biotools are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Standard Biotools' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Standard Biotools current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.At present, Standard Biotools' Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 102.8 M, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.
 2021 2022 2023 2024 (projected)
Interest Expense3.8M4.3M4.6M4.5M
Depreciation And Amortization23.2M15.0M15.2M10.8M

Standard Biotools fundamental ratios Correlations

0.390.720.360.280.460.790.7-0.550.620.380.950.440.590.860.510.40.680.890.660.730.770.760.050.490.07
0.390.41-0.150.24-0.220.050.440.15-0.120.310.350.590.310.34-0.210.120.230.25-0.020.060.180.34-0.28-0.23-0.2
0.720.410.410.490.320.660.49-0.460.480.540.740.440.270.740.43-0.10.250.660.340.660.350.440.090.440.07
0.36-0.150.410.480.750.460.1-0.860.570.20.32-0.130.230.370.790.15-0.10.50.320.520.230.330.930.80.8
0.280.240.490.480.180.180.16-0.270.4-0.130.30.190.010.610.370.13-0.490.260.30.35-0.330.140.380.350.3
0.46-0.220.320.750.180.70.02-0.870.830.270.42-0.230.240.440.890.090.210.70.560.710.440.380.590.880.65
0.790.050.660.460.180.70.42-0.770.810.420.810.260.270.70.780.00.530.890.750.930.640.480.130.780.19
0.70.440.490.10.160.020.42-0.090.18-0.070.820.710.070.510.00.130.550.570.360.210.570.22-0.11-0.02-0.07
-0.550.15-0.46-0.86-0.27-0.87-0.77-0.09-0.74-0.41-0.480.08-0.39-0.47-0.96-0.16-0.22-0.71-0.54-0.82-0.49-0.51-0.68-0.96-0.64
0.62-0.120.480.570.40.830.810.18-0.740.120.6-0.080.250.710.830.210.180.80.750.860.330.450.330.80.28
0.380.310.540.2-0.130.270.42-0.07-0.410.120.250.040.550.250.31-0.120.420.30.00.440.460.540.030.360.09
0.950.350.740.320.30.420.810.82-0.480.60.250.540.310.830.460.180.630.870.660.690.710.52-0.010.440.06
0.440.590.44-0.130.19-0.230.260.710.08-0.080.040.54-0.020.43-0.13-0.060.330.360.350.110.290.11-0.32-0.15-0.17
0.590.310.270.230.010.240.270.07-0.390.250.550.31-0.020.420.290.760.50.410.240.40.560.960.160.270.04
0.860.340.740.370.610.440.70.51-0.470.710.250.830.430.420.540.310.310.780.760.730.410.630.070.510.11
0.51-0.210.430.790.370.890.780.0-0.960.830.310.46-0.130.290.540.130.120.690.630.850.370.440.590.990.63
0.40.12-0.10.150.130.090.00.13-0.160.21-0.120.18-0.060.760.310.130.270.250.290.130.310.730.20.070.02
0.680.230.25-0.1-0.490.210.530.55-0.220.180.420.630.330.50.310.120.270.560.370.330.940.56-0.30.12-0.14
0.890.250.660.50.260.70.890.57-0.710.80.30.870.360.410.780.690.250.560.730.850.680.620.20.660.19
0.66-0.020.340.320.30.560.750.36-0.540.750.00.660.350.240.760.630.290.370.730.70.450.450.080.590.18
0.730.060.660.520.350.710.930.21-0.820.860.440.690.110.40.730.850.130.330.850.70.460.580.220.840.18
0.770.180.350.23-0.330.440.640.57-0.490.330.460.710.290.560.410.370.310.940.680.450.460.630.010.370.16
0.760.340.440.330.140.380.480.22-0.510.450.540.520.110.960.630.440.730.560.620.450.580.630.170.420.08
0.05-0.280.090.930.380.590.13-0.11-0.680.330.03-0.01-0.320.160.070.590.2-0.30.20.080.220.010.170.610.79
0.49-0.230.440.80.350.880.78-0.02-0.960.80.360.44-0.150.270.510.990.070.120.660.590.840.370.420.610.64
0.07-0.20.070.80.30.650.19-0.07-0.640.280.090.06-0.170.040.110.630.02-0.140.190.180.180.160.080.790.64
Click cells to compare fundamentals

Standard Biotools Account Relationship Matchups

Standard Biotools fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets264.8M324.8M275.2M390.3M323.1M228.8M
Short Long Term Debt Total60.0M95.4M111.6M102.7M98.2M104.4M
Other Current Liab12.7M25.6M12.2M10.5M19.3M12.6M
Total Current Liabilities32.8M54.2M49.6M43.4M109.3M114.8M
Total Stockholder Equity153.6M139.1M94.6M(81.5M)163.2M171.4M
Property Plant And Equipment Net12.9M55.6M65.2M59.5M54.9M57.6M
Current Deferred Revenue11.8M13.5M15.5M14.4M11.6M7.8M
Net Debt38.3M26.9M83.2M21.3M46.5M49.6M
Retained Earnings(623.6M)(676.8M)(736.0M)(926.1M)(1.0B)(950.7M)
Accounts Payable6.5M9.2M10.6M7.9M9.2M5.5M
Cash21.7M68.5M28.5M81.3M51.7M43.2M
Non Current Assets Total168.7M207.1M203.1M181.5M164.9M124.5M
Non Currrent Assets Other5.5M4.7M3.7M3.1M2.3M4.4M
Cash And Short Term Investments58.6M68.5M28.5M165.8M114.9M72.5M
Net Receivables19.0M25.4M18.3M17.3M19.7M15.4M
Common Stock Shares Outstanding66.8M72.0M75.8M78.3M79.2M83.1M
Short Term Investments5.1M0.037.0M84.5M63.2M35.1M
Liabilities And Stockholders Equity264.8M324.8M275.2M390.3M323.1M228.8M
Non Current Liabilities Total78.4M131.5M131.1M428.3M50.5M48.0M
Inventory13.9M19.7M20.8M21.5M20.5M13.6M
Other Current Assets4.6M4.0M4.5M4.3M3.1M2.8M
Other Stockholder Equity777.8M815.6M831.4M846.4M854.8M467.6M
Total Liab111.2M185.7M180.6M471.8M159.9M205.2M
Total Current Assets96.1M117.7M72.1M208.8M158.2M104.3M
Accumulated Other Comprehensive Income(582K)112K(907K)(1.9M)(2.2M)(2.1M)
Short Term Debt1.8M5.9M9.9M9.4M68.2M71.6M
Common Stock70K75K77K80K83K87.2K
Intangible Assets46.2M40.2M27.9M12.6M1.4M1.3M
Other Assets2.6M2.7M2.4M3.1M2.8M3.4M
Long Term Debt53.8M54.2M64.2M62.8M4.0M3.8M
Long Term Debt Total53.8M54.2M64.2M62.8M56.5M91.1M
Capital Surpluse777.8M815.6M831.4M847.0M974.1M774.5M
Cash And Equivalents5.0M20.7M28.5M81.3M93.5M98.2M
Property Plant Equipment12.9M55.6M65.2M59.5M68.5M36.3M
Other Liab20.2M39.1M29.3M20.2M23.2M28.7M
Net Tangible Assets372K(9.7M)(41.0M)110.9M127.6M134.0M
Net Invested Capital207.4M193.3M165.6M(16.6M)(84.5M)(80.3M)
Capital Stock70K75K77K(81.5M)83K87.2K
Non Current Liabilities Other573K1.3M882K961K1.1M888.5K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Standard Biotools offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Standard Biotools' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Standard Biotools Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Standard Biotools Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Standard Biotools. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.69)
Revenue Per Share
0.558
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.15)
Return On Equity
(0.37)
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.